NIH-funded research NIH-funded research

Oklahoma Immunomodulation Center to Bring New Tools and Training

Official title: Alteration and Renovation (A&R) Project

Funded at University of Oklahoma · NIH-11269430 · Data updated 2026-11-12

A new center in Oklahoma will bring cutting-edge immunomodulation technologies and data science support to researchers, helping doctors and patients by accelerating immune-related discoveries.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Oklahoma
NIH-funded
Lab location1 site (Norman, United States)
Project startMay 15, 2026
Project endJanuary 31, 2031
Funding year2026
Award (this year)$419,695
NIH project number1P20GM162339-01
Project IDNIH-11269430 on NIH RePORTER

Who could benefit from this research

Could help

Researchers and clinicians in Oklahoma and IDeA states who study immune modulation and related omics data and need access to advanced instrumentation and training.

Less likely to help

Individual patients are not directly enrolled in this grant; benefits come through accelerated research and future therapies.

What this research studies

This grant funds establish the Oklahoma Center of ImmunoEngineering to connect immunmodulation methods with omics data analysis across Oklahoma and nearby states. It creates the Immunomodulation Technology Core to share expensive instruments, offer hands-on training, and provide expert technical support so labs can adopt advanced immune engineering tools. The center will also coordinate with local institutions to centralize resources, reduce costs, and speed up translational work that could eventually impact patient care. By helping early-career researchers access and master new technologies, the program aims to grow a robust immunology research ecosystem in the region.

Why it matters

Potential benefit: If successful, patients could benefit from faster development of immune-related therapies and diagnostics through a stronger regional research network.

How similar studies have gone: Centers like COBREs have previously strengthened regional capabilities and sometimes led to new technologies reaching patient care.

Where this research is happening

  • University of Oklahoma
    Norman, United States
    Active

Researchers

  • Principal investigator: Chen, Wei R. — University of Oklahoma
  • Study coordinator: Chen, Wei R.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.